Ranbaxy Laboratories Ltd announced on Tuesday an exclusive in-licensing agreement with CD Pharma to market the Inersan brand in India and Nepal.
The patented product, a probiotic preparation, is used for the treatment of dental problems such as periodontitis, gingivitis and halitosis. Presently, there is no particular drug available for the treatment of this dental problem. Inersan, a natural biological product, would be the first-of-its-kind to be introduced in India.
THE BAD BREATH COMMUNITY
A little more connection.
A little more connection.
A little less alone.
Real experiences. Open conversations. A place to feel understood.
THE BAD BREATH EBOOK Discover the ebook ↗
POWERED BY PEOPLE LIKE YOU
Donate to the forum ♡
Keep the conversation going.
Your donation helps cover hosting and keep this community available.
New Halitosis Treatment Product "Inersan"
I can't find any information besides pubmed saying these are "lactobacilli lozenges" which makes it no different than yogurt. The company creates a very high-potency probiotic product containing 250 billion bacteria called VSL#3, so Inersan could be a concoction with very high concentrations of bacteria in the form of a lozenge. It could very well be the same product, in lozenge form, made for India/Nepal
Discover the Bad Breath ebook Explore the ebook ↗
ADVERTISING OPPORTUNITIES
Advertise here ↗
Your banner. Right here.
Introduce your brand to the Bad Breath Halitosis community.